The FDA added a new warning.
This new warning comes after the FDA received 100 preliminary reports of people developing Guillain-Barré syndrome after getting the Johnson & Johnson vaccine, the. For context, that's out of 12.8 million doses of the vaccine administered. The cases appeared around two weeks after vaccination and were more common in men and people older than 50.
It's not clear yet whether or not the vaccine directly caused the condition, but the Centers for Disease Control and Prevention toldthere is a “small possible risk” for the condition associated with the vaccine. Experts are expected to discuss that potential risk at a meeting of the CDC's Advisory Committee on Immunization Practices later this week.
Experts don't know exactly what causes the condition, but it can develop after a gastrointestinal or respiratory illness, includingand COVID-19, the Mayo Clinic explains. People who develop Guillain-Barré syndrome typically require hospitalization. Although there's no cure for the condition, treatment including immunoglobulin therapy, plasma exchange, and physical therapy can help most patients regain mobility and motor strength, the.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA expected to add Guillain-Barre syndrome warning to J&J Covid shotThe FDA is preparing to add a warning to Johnson & Johnson's Covid-19 vaccine after receiving preliminary reports of patients developing the rare neurological condition Guillain-Barré syndrome
Leer más »
J&J confirms it's talking to FDA about risk of Guillain-Barre syndrome with its Covid-19 vaccineAccording to a CNN medical analyst, a third of new Covid-19 cases are coming from five hot spots: Florida, Louisiana, Arkansas, Missouri and Nevada. Follow here for the latest news on vaccines and the Delta variant.
Leer más »
Johnson & Johnson in discussion with FDA regarding COVID-19 vaccine side effectsJohnson & Johnson (JNJ.N) said on Monday it was in discussions with the U.S. Food and Drug Administration about rare cases of a neurological disorder, Guillain-Barré syndrome, that have been reported following vaccination with the Janssen COVID-19 vaccine.
Leer más »
FDA Adds Warning Of Rare Autoimmune Disorder To J&J VaccineRegulators said the risk of getting Guillain-Barré syndrome from the Johnson & Johnson COVID-19 vaccine was low.
Leer más »